Moreover, trichostatin A [TSA; a histone deacetylase (HDAC) inhibitor], as one of the most common treatment methods to induce apoptosis in human cancer cells, induces overexpression of STC1 through activation of p53 in cancer cells.62 This evidence concerns the gene TP53 and cancer.